The strategies of drug supply for patients with chronic hepatitis C
| Autor: | D. A. Andreev, V. A. Dubovtseva, K. А. Kokushkin, A. D. Ermolaeva, A. g Pokatilo, E. V. Kornilova, K. I. Polyakova, M. V. Davydovskaya, M. G. Rusanova, A. V. Devyatkin, T. N. Ermolaeva |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2017 |
| Předmět: |
Drug supply
medicine.medical_specialty risk-sharing scheme RM1-950 drug supply Medical care Chronic hepatitis antiviral therapy medicine In patient Chronic viral hepatitis C Intensive care medicine HB71-74 Pharmacology business.industry Health Policy Mortality rate Public Health Environmental and Occupational Health Antiviral therapy innovative model of drug supply hcv infection pilot project Economics as a science chronic hepatitis c Russian federation Therapeutics. Pharmacology business |
| Zdroj: | Фармакоэкономика, Vol 10, Iss 3, Pp 34-46 (2017) |
| ISSN: | 2070-4933 2070-4909 |
| Popis: | The report reviews the options of drug supply for patients with chronic hepatitis C in the Russian Federation and elsewhere. The results of the Moscow regional program aimed at improving the quality of medical care in such patients are discussed. The proposed measures contribute to the reduced mortality rate in patients suffering from infections. The prospects of further improvements in the availability of antiviral medications for patients with chronic viral hepatitis C are outlined. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|